Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01935011 · ClinicalTrials.gov registry record
DBS Frequency on Swallowing Function in Parkinson's Disease
A clinical trial, sponsored by University of Chicago.
- Completed
- Registry status
- 7
- Enrollment target
NCT01935011 is a clinical trial that has completed, run by University of Chicago. The registered enrollment target is 7 participants.
The verdict
NCT01935011 has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The stimulation frequency has been found to affect the axial symptoms of freezing of gait (FOG) and speech in advanced Parkinson's disease (PD) patients with subthalamic nucleus deep brain stimulation (STN DBS), with the traditionally high stimulation frequency of 130 Hz worsening while low frequency of 60 Hz improving these symptoms. The effect of stimulation frequency on another important axial symptom, swallowing dysfunction, has not been studied. The investigators hypothesize that stimulation frequency could have similar effect on swallowing function.
Interventions
- OTHER PD, DBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01935011
The ClinicalTrials.gov registry entry for NCT01935011 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PD, DBS is the first listed.
NCT01935011 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01935011 about?
NCT01935011 is a clinical study titled "DBS Frequency on Swallowing Function in Parkinson's Disease". The stimulation frequency has been found to affect the axial symptoms of freezing of gait (FOG) and speech in advanced Parkinson's disease (PD) patients with subthalamic nucleus deep brain stimulation (STN DBS), with the traditionally high stimulation frequency of 130 Hz worsening while low frequenc...
What is the current status of trial NCT01935011?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2013-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01935011?
The interventions under investigation include: PD, DBS (OTHER).
Who is sponsoring clinical trial NCT01935011?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.